Mirvaso® Gel and Dysport® for Erythema and Flushing of Rosacea
Condition(s):Erythema and Flushing Associated With RosaceaLast Updated:April 18, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Erythema and Flushing Associated With RosaceaLast Updated:April 18, 2023Terminated
Condition(s):Overactive BladderLast Updated:October 13, 2023Completed
Condition(s):MigraineLast Updated:October 8, 2020Completed
Condition(s):Dermatological Non-DiseaseLast Updated:September 24, 2021Completed
Condition(s):Glabellar Frown Lines (GL); Lateral Canthal Lines (LCL)Last Updated:September 6, 2023Completed
Condition(s):Glabellar Lines; Lateral Canthal LinesLast Updated:June 18, 2023Completed
Condition(s):SclerodermaLast Updated:April 28, 2021Completed
Condition(s):Erectile DysfunctionLast Updated:September 21, 2023Recruiting
Condition(s):Raynaud PhenomenonLast Updated:March 5, 2024Recruiting
Condition(s):Esophageal Achalasia; Esophageal Spasm, Diffuse; Esophageal Motility DisordersLast Updated:January 12, 2018Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.